Bacitracin used in this study was donated by Commercial Solvents Corporation, New York.
Instructor in Dermatology, Georgetown University School of Medicine, and attending staff physician, Walter Reed General Hospital (Dr. Derzavis).
The opinions expressed are those of the authors and are not to be considered the official opinion of the medical department of the United States Army.
Clinical studies herein reported were carried out at the Walter Reed General Hospital and in the Division of Dermatology, Georgetown University Service, Gallinger Municipal Hospital.
The literature is replete with evidence of the high index of allergenicity of the more effective agents used in the therapy of the various pyodermas. The alarming incidence of the apparent induction of hypersensitivity to such valuable medicaments as sulfonamide drugs and penicillin when they are used topically to treat the minor dermatoses, thus vitiating their future usefulness in generalized and systemic infections, has prompted the cautioning editorial by Sulzberger and Baer in the "Year Book of Dermatology."1 It is therefore expedient that information concerning the useful and less allergenic therapeutic agents be promulgated widely. We are reporting some significant clinical results which we have noted following the topical administration of a new antibiotic, bacitracin. These results corroborate the findings of Miller, Slatkin and Johnson reported recently in the Journal of Investigative Dermatology.2
HISTORICAL DATA In Science (Oct. 12, 1945) Johnson, Anker and Meleney3 reported the recovery
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.